These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31974262)

  • 21. Metastatic Ocular Melanoma Presenting as a Heart-Compressing Mediastinal Mass.
    Kiparakis M; Lazopoulos G; Koutsopoulos A; Gavalaki A; Kampitakis E; Chalkiadakis G
    Ann Thorac Surg; 2015 Oct; 100(4):1448-50. PubMed ID: 26434443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib.
    Lacroix JP; Wang B
    J Cutan Med Surg; 2017; 21(1):54-59. PubMed ID: 27624900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
    Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib.
    Jafri S; Yaqub A
    Cureus; 2021 Aug; 13(8):e17488. PubMed ID: 34595070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective.
    Gerbasi ME; Stellato D; Ghate SR; Ndife B; Moynahan A; Mishra D; Gunda P; Koruth R; Delea TE
    J Med Econ; 2019 Dec; 22(12):1243-1252. PubMed ID: 31223037
    [No Abstract]   [Full Text] [Related]  

  • 26. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
    Paolino G; Panetta C; Didona D; Donati M; Donati P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.
    Long GV; Stroyakovskiy D; Gogas H; Levchenko E; de Braud F; Larkin J; Garbe C; Jouary T; Hauschild A; Grob JJ; Chiarion Sileni V; Lebbe C; Mandalà M; Millward M; Arance A; Bondarenko I; Haanen JB; Hansson J; Utikal J; Ferraresi V; Kovalenko N; Mohr P; Probachai V; Schadendorf D; Nathan P; Robert C; Ribas A; DeMarini DJ; Irani JG; Casey M; Ouellet D; Martin AM; Le N; Patel K; Flaherty K
    N Engl J Med; 2014 Nov; 371(20):1877-88. PubMed ID: 25265492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant melanoma of mediastinum misdiagnosed as a spindle cell thymoma in a fine needle aspirate: a case report.
    Bavi P; Shet T; Gujral S
    Acta Cytol; 2005; 49(4):424-6. PubMed ID: 16124173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive 57Co-bleomycin scintigraphy in silent mediastinal metastases of malignant melanoma.
    Valdés Olmos RA; van der Bergh JH; den Hamer JF; Serdijn HJ
    Eur J Nucl Med; 1985; 10(1-2):86-7. PubMed ID: 2579816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
    Long GV; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Schachter J; Schadendorf D; Lesimple T; Plummer R; Ji R; Zhang P; Mookerjee B; Legos J; Kefford R; Dummer R; Kirkwood JM
    N Engl J Med; 2017 Nov; 377(19):1813-1823. PubMed ID: 28891408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma.
    Si L; Zhang X; Shin SJ; Fan Y; Lin CC; Kim TM; Dechaphunkul A; Maneechavakajorn J; Wong CS; Ilankumaran P; Lee DY; Gasal E; Li H; Guo J
    Eur J Cancer; 2020 Aug; 135():31-38. PubMed ID: 32534242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating malignant melanoma when a rare BRAF V600M mutation is present: case report and literature review.
    Popescu A; Haidar A; Anghel RM
    Rom J Intern Med; 2018 Jun; 56(2):122-126. PubMed ID: 29168975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small cell type malignant melanoma which developed in a 16-year-old female with a congenital dermal nevus and metastasized 12 years after excision.
    Miura K; Harada H; Tsutsui Y
    Pathol Int; 1999 Mar; 49(3):247-52. PubMed ID: 10338082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary malignant melanoma of the thymus: report of a case.
    Taniguchi T; Kawaguchi K; Fukui T; Nishimura M; Yokoi K
    Surg Today; 2015 Sep; 45(9):1187-9. PubMed ID: 25069423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant Melanoma Presenting as a Mediastinal Malignant Melanoma Presenting as a Mediastinal Unknown Primary Origin?
    Pujani M; Hassan MJ; Jetley S; Raina PK; Kumar M
    Turk Patoloji Derg; 2017; 33(2):168-170. PubMed ID: 25652557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
    Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
    Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An unusual mediastinal mass].
    Bousquet E; Pontier S; Hermant C; Rouquette I; Meyer N; Didier A; Mazieres J
    Rev Mal Respir; 2014 Sep; 31(7):624-7. PubMed ID: 25239585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma.
    Ponti G; Tomasi A; Pellacani G
    J Hematol Oncol; 2012 Oct; 5():60. PubMed ID: 23031422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic paraganglioma of the anterior mediastinum.
    Ortega PF; Sosa LA; Patel M; Zambrano E
    Ann Diagn Pathol; 2010 Oct; 14(5):341-6. PubMed ID: 20850697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature.
    Juhlin CC; Zedenius J; Haglund F
    J Med Case Rep; 2020 Mar; 14(1):44. PubMed ID: 32234068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.